These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10190950)

  • 61. Efficacy and safety of high-dose chemotherapy with in vivo purged auto-SCT in relapsed follicular lymphoma: long-term follow-up.
    Magni M; Di Nicola M; Carlo-Stella C; Devizzi L; Guidetti A; Matteucci P; Gianni AM
    Bone Marrow Transplant; 2010 Jun; 45(6):1119-20. PubMed ID: 19820728
    [No Abstract]   [Full Text] [Related]  

  • 62. Salvage treatment with upfront melphalan 100 mg/m(2) and consolidation with novel drugs for fulminant progression of multiple myeloma.
    Krejci M; Adam Z; Buchler T; Krivanova A; Pour L; Zahradova L; Holanek M; Sandecka V; Mayer J; Vorlicek J; Hajek R
    Ann Hematol; 2010 May; 89(5):483-7. PubMed ID: 19924414
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Durable event-free survival following autologous stem cell transplant for relapsed or refractory follicular lymphoma: positive impact of recent rituximab exposure and low-risk Follicular Lymphoma International Prognostic Index score.
    Peters AC; Duan Q; Russell JA; Duggan P; Owen C; Stewart DA
    Leuk Lymphoma; 2011 Nov; 52(11):2124-9. PubMed ID: 21740097
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience.
    Viviani S; Di Nicola M; Bonfante V; Di Stasi A; Carlo-Stella C; Matteucci P; Magni M; Devizzi L; Valagussa P; Gianni AM
    Leuk Lymphoma; 2010 Jul; 51(7):1251-9. PubMed ID: 20528244
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Autologous blood stem cell transplantation as intensive consolidation therapy in hematological malignancies.
    Fioritoni G; Iacone A; D'Antonio D; Dragani A; Quaglietta AM; Accorsi P; Angelini A; Spadano A; Natale D; Berardi A
    Haematologica; 1990; 75 Suppl 1():60-4. PubMed ID: 1972130
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Autologous Stem Cell Transplants Taking Breast and Ovarian Cancer Chemotherapy to New Heights.
    Stewart D
    Medscape Womens Health; 1996 Jul; 1(7):2. PubMed ID: 9746632
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Autologous blood cell transplantation in B-CLL: response to chemotherapy prior to mobilization predicts the stem cell yield.
    Itälä M; Pelliniemi TT; Rajamäki A; Remes K
    Bone Marrow Transplant; 1997 Apr; 19(7):647-51. PubMed ID: 9156240
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group.
    Jurinovic V; Metzner B; Pfreundschuh M; Schmitz N; Wandt H; Keller U; Dreger P; Dreyling M; Hiddemann W; Unterhalt M; Hoster E; Weigert O
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1172-1179. PubMed ID: 29605716
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review.
    Oliansky DM; Gordon LI; King J; Laport G; Leonard JP; McLaughlin P; Soiffer RJ; van Besien KW; Werner M; Jones RB; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):443-68. PubMed ID: 20114084
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Quantifying Benefit of Autologous Transplantation for Relapsed Follicular Lymphoma Patients via Instrumental Variable Analysis.
    Oh DH; Li H; Duan Q; Villa D; Peters A; Chua N; Owen CJ; Connors JM; Stewart DA
    Biol Blood Marrow Transplant; 2016 May; 22(5):941-8. PubMed ID: 26785331
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of different strategies of molecular genetic monitoring following autologous stem cell transplantation in patients with follicular lymphoma.
    von Neuhoff N; Dreger P; Suttorp M; Marget M; Kell S; Schmitz N
    Bone Marrow Transplant; 1998 Jul; 22(2):161-6. PubMed ID: 9707024
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group.
    Lenz G; Dreyling M; Schiegnitz E; Forstpointner R; Wandt H; Freund M; Hess G; Truemper L; Diehl V; Kropff M; Kneba M; Schmitz N; Metzner B; Pfirrmann M; Unterhalt M; Hiddemann W;
    Blood; 2004 Nov; 104(9):2667-74. PubMed ID: 15238420
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma.
    Vose JM; Bierman PJ; Lynch JC; Weisenburger DD; Kessinger A; Chan WC; Greiner TC; Armitage JO
    J Clin Oncol; 1998 Mar; 16(3):844-9. PubMed ID: 9508164
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma.
    Bierman PJ; Vose JM; Anderson JR; Bishop MR; Kessinger A; Armitage JO
    J Clin Oncol; 1997 Feb; 15(2):445-50. PubMed ID: 9053464
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High-dose chemotherapy followed by autologous stem cell transplantation for patients with refractory/relapsed classical Hodgkin lymphoma: a single center experience from China.
    Xie Y; Wang X; Leng X; Zheng W; Ping L; Zhang C; Liu W; Deng L; Wu M; Song Y; Zhu J
    Ann Hematol; 2020 Mar; 99(3):549-555. PubMed ID: 31980860
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphoma.
    Jiménez-Ubieto A; Grande C; Caballero D; Yáñez L; Novelli S; Hernández MT; Manzanares M; Arranz R; Ferreiro JJ; Bobillo S; Mercadal S; Galego A; Jiménez JL; Moraleda JM; Vallejo C; Albo C; Pérez E; Marrero C; Magnano L; Palomera L; Jarque I; Coria E; Rodriguez A; Martín A; López-Guillermo A; Salar A; Lahuerta JJ;
    Cancer Med; 2017 Dec; 6(12):2766-2774. PubMed ID: 29076254
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years.
    Gyan E; Foussard C; Bertrand P; Michenet P; Le Gouill S; Berthou C; Maisonneuve H; Delwail V; Gressin R; Quittet P; Vilque JP; Desablens B; Jaubert J; Ramée JF; Arakelyan N; Thyss A; Moluçon-Chabrot C; Delépine R; Milpied N; Colombat P; Deconinck E;
    Blood; 2009 Jan; 113(5):995-1001. PubMed ID: 18955565
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Controversies in the treatment of lymphoma with autologous transplantation.
    Moskowitz AJ; Moskowitz CH
    Oncologist; 2009 Sep; 14(9):921-9. PubMed ID: 19737999
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long-term follow-up demonstrates curative potential of autologous stem cell transplantation for relapsed follicular lymphoma.
    Puckrin R; Chua N; Chin K; Peters A; Duggan P; Shafey M; Storek J; Jamani K; Owen C; Stewart D
    Br J Haematol; 2023 Apr; 201(2):319-325. PubMed ID: 36625160
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol.
    Brice P; Simon D; Bouabdallah R; Bélanger C; Haïoun C; Thieblemont C; Tilly H; Harousseau JL; Doyen C; Martin C; Brousse N; Solal-Céligny PH;
    Ann Oncol; 2000 Dec; 11(12):1585-90. PubMed ID: 11205467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.